ScholarIQanswers from OpenAlex

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib

PaperCitations, authors & open-access status

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib have?

ScholarIQcitation count

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib has 219 citations in the OpenAlex counts ScholarIQ stores.

When was Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib published?

ScholarIQyear

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib has 2016 year in the ScholarIQ index.

What is the open-access status of Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib?

ScholarIQoa status

Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib has closed oa status in the ScholarIQ index.

What is the DOI of Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib?

ScholarIQdoi

The DOI for Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib is on the source record.

What is the PMID of Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib?

ScholarIQpmid

The PMID for Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib is on the source record.

What is the OpenAlex record for Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib?

ScholarIQopenalex

The OpenAlex for Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial